Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Devilee

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Lancet (London, England)|July 4, 1998
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1L C Verhoog, C T Brekelmans, C Seynaeve, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Survival in hereditary breast cancer associated with germline mutations of BRCA2L C Verhoog, C T Brekelmans, C Seynaeve, et al.
Oncogene|August 30, 2000
Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22N Rahman, M D Teare, S Seal, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2001
Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer familiesL C Verhoog, A M van den Ouweland, E Berns, et al.
International Journal of Cancer|July 15, 1998
BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristicsT M Wagner, R A Möslinger, D Muhr, et al.
Cancer Research|April 29, 2000
Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancerE M Berns, J A Foekens, R Vossen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2006
Association between the CHEK2*1100delC germ line mutation and estrogen receptor statusG H de Bock, M J E Mourits, M Schutte, et al.
Nature Genetics|November 14, 1997
BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patientsA Petrij-Bosch, T Peelen, M van Vliet, et al.
Journal of Medical Genetics|October 3, 1999
Linkage analysis of 56 multiplex families excludes the Cowden disease gene PTEN as a major contributor to familial breast cancerY Y Shugart, C Cour, H Renard, et al.
Cytogenetics and Cell Genetics|January 1, 1996
Report of the Fifth International Workshop on Human Chromosome 11 Mapping 1996T B Shows, M Alders, S Bennett, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Lancet (London, England)|July 4, 1998
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1L C Verhoog, C T Brekelmans, C Seynaeve, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Survival in hereditary breast cancer associated with germline mutations of BRCA2L C Verhoog, C T Brekelmans, C Seynaeve, et al.
Oncogene|August 30, 2000
Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22N Rahman, M D Teare, S Seal, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2001
Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer familiesL C Verhoog, A M van den Ouweland, E Berns, et al.
International Journal of Cancer|July 15, 1998
BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristicsT M Wagner, R A Möslinger, D Muhr, et al.
Cancer Research|April 29, 2000
Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancerE M Berns, J A Foekens, R Vossen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2006
Association between the CHEK2*1100delC germ line mutation and estrogen receptor statusG H de Bock, M J E Mourits, M Schutte, et al.
Nature Genetics|November 14, 1997
BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patientsA Petrij-Bosch, T Peelen, M van Vliet, et al.
Journal of Medical Genetics|October 3, 1999
Linkage analysis of 56 multiplex families excludes the Cowden disease gene PTEN as a major contributor to familial breast cancerY Y Shugart, C Cour, H Renard, et al.
Cytogenetics and Cell Genetics|January 1, 1996
Report of the Fifth International Workshop on Human Chromosome 11 Mapping 1996T B Shows, M Alders, S Bennett, et al.
Pageof 12